Skip to content

The effects of choice theory on behavioral problems

A clinical trial to comparison the effectiveness of choice theory on behavioral problems in attention deficit hyperactivity disorder (ADHD) with oppositional defiant disorder (ODD) patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017011431920N1
Enrollment
32
Registered
2017-05-21
Start date
2017-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Attention deficit hyperactivity disorder (ADHD). Condition 2: Oppositional defiant disorder (ODD). Disturbance of activity and attention Oppositional defiant disorder

Interventions

Intervention 1: Intervention group: Who received the standard treatment for ADHD (1-10 mg/kg ritalin and 10 mg risperidone per day) and received five 120-minute sessions of training based on choice th
Treatment - Other
Intervention group: Who received the standard treatment for ADHD (1-10 mg/kg ritalin and 10 mg risperidone per day) and received five 120-minute sessions of training based on choice theory for five co
Control group: Who received the standard treatment for ADHD (1-10 mg/kg ritalin and 10 mg risperidone per day) along with group sessions similar to the intervention group, but without any special theo

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) patients base on DSM-V criteria; aged between 12 and 18 years; no signs of systemic diseases and other psychological diseases; history of normal IQ; have the standard drug treatment in the last of 3 to 12 months. Exclusion criteria: Unwillingness to continue the study; incidence of systemic diseases and other psychological diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Strengths and difficulties. Timepoint: Before, 1 and 4 weeks after the intervention. Method of measurement: Strengths and Difficulties Questionnaire (SDQ).;Oppositional defiant disorder. Timepoint: Before, 1 and 4 weeks after the intervention. Method of measurement: Oppositional Defiant Disorder (ODD) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdieh Fatemi Naeri

Mashhad University of Medical Sciences

mahdiehfatemi@yahoo.com+98 51 3711 2701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026